End-of-day quote
Taiwan S.E.
06:00:00 2024-04-29 pm EDT
|
5-day change
|
1st Jan Change
|
11.25
TWD
|
-.--%
|
|
+10.29%
|
+15.15%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
29,563
|
27,782
|
38,269
|
43,196
|
37,394
|
36,978
|
Enterprise Value (EV)
1 |
20,478
|
34,276
|
49,943
|
74,012
|
72,497
|
80,591
|
P/E ratio
|
6.93
x
|
16.1
x
|
56
x
|
12.1
x
|
165
x
|
-34.9
x
|
Yield
|
4.57%
|
3.06%
|
-
|
3.04%
|
-
|
-
|
Capitalization / Revenue
|
0.77
x
|
0.94
x
|
2.18
x
|
1.23
x
|
1.49
x
|
1.4
x
|
EV / Revenue
|
0.53
x
|
1.16
x
|
2.84
x
|
2.1
x
|
2.9
x
|
3.05
x
|
EV / EBITDA
|
4.59
x
|
35.7
x
|
-55.6
x
|
20.8
x
|
-27.5
x
|
-47.6
x
|
EV / FCF
|
11.8
x
|
-2.51
x
|
-6.98
x
|
-2.32
x
|
-8.31
x
|
-9.73
x
|
FCF Yield
|
8.44%
|
-39.8%
|
-14.3%
|
-43.2%
|
-12%
|
-10.3%
|
Price to Book
|
0.44
x
|
0.41
x
|
0.54
x
|
0.62
x
|
0.47
x
|
0.47
x
|
Nbr of stocks (in thousands)
|
2,834,850
|
2,834,850
|
3,284,850
|
3,284,850
|
3,784,850
|
3,784,850
|
Reference price
2 |
10.43
|
9.800
|
11.65
|
13.15
|
9.880
|
9.770
|
Announcement Date
|
3/28/19
|
3/30/20
|
3/25/21
|
3/16/22
|
3/15/23
|
3/15/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
38,503
|
29,624
|
17,583
|
35,163
|
25,028
|
26,414
|
EBITDA
1 |
4,458
|
961.1
|
-898.7
|
3,557
|
-2,641
|
-1,695
|
EBIT
1 |
3,075
|
-409
|
-1,813
|
2,514
|
-3,846
|
-3,051
|
Operating Margin
|
7.99%
|
-1.38%
|
-10.31%
|
7.15%
|
-15.37%
|
-11.55%
|
Earnings before Tax (EBT)
1 |
4,677
|
1,863
|
103.8
|
3,990
|
723.4
|
-585.1
|
Net income
1 |
4,290
|
1,738
|
681
|
3,603
|
233.1
|
-1,060
|
Net margin
|
11.14%
|
5.87%
|
3.87%
|
10.25%
|
0.93%
|
-4.01%
|
EPS
2 |
1.505
|
0.6100
|
0.2080
|
1.090
|
0.0600
|
-0.2801
|
Free Cash Flow
1 |
1,729
|
-13,635
|
-7,156
|
-31,958
|
-8,728
|
-8,285
|
FCF margin
|
4.49%
|
-46.03%
|
-40.7%
|
-90.88%
|
-34.87%
|
-31.37%
|
FCF Conversion (EBITDA)
|
38.79%
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
40.31%
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
0.4762
|
0.3000
|
-
|
0.4000
|
-
|
-
|
Announcement Date
|
3/28/19
|
3/30/20
|
3/25/21
|
3/16/22
|
3/15/23
|
3/15/24
|
Fiscal Period: December |
2022 Q1
|
2022 Q2
|
---|
Net sales
1 |
7,382
|
8,139
|
EBITDA
|
-
|
-
|
EBIT
1 |
-504.7
|
-442.5
|
Operating Margin
|
-6.84%
|
-5.44%
|
Earnings before Tax (EBT)
1 |
-328.1
|
-463.5
|
Net income
1 |
-331.3
|
-455.2
|
Net margin
|
-4.49%
|
-5.59%
|
EPS
2 |
-0.0900
|
-0.1200
|
Dividend per Share
|
-
|
-
|
Announcement Date
|
5/12/22
|
8/15/22
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
6,494
|
11,675
|
30,816
|
35,103
|
43,613
|
Net Cash position
1 |
9,085
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
6.758
x
|
-12.99
x
|
8.664
x
|
-13.29
x
|
-25.73
x
|
Free Cash Flow
1 |
1,729
|
-13,635
|
-7,156
|
-31,958
|
-8,728
|
-8,285
|
ROE (net income / shareholders' equity)
|
6.6%
|
2.58%
|
0.98%
|
4.75%
|
0.26%
|
-1.37%
|
ROA (Net income/ Total Assets)
|
2.24%
|
-0.27%
|
-1.13%
|
1.31%
|
-1.74%
|
-1.33%
|
Assets
1 |
191,240
|
-633,084
|
-60,522
|
275,559
|
-13,402
|
79,738
|
Book Value Per Share
2 |
23.60
|
23.70
|
21.60
|
21.30
|
21.00
|
20.80
|
Cash Flow per Share
2 |
4.750
|
3.220
|
2.280
|
2.020
|
1.800
|
1.460
|
Capex
1 |
4,046
|
5,299
|
3,862
|
4,194
|
3,211
|
1,858
|
Capex / Sales
|
10.51%
|
17.89%
|
21.96%
|
11.93%
|
12.83%
|
7.04%
|
Announcement Date
|
3/28/19
|
3/30/20
|
3/25/21
|
3/16/22
|
3/15/23
|
3/15/24
|
|
1st Jan change
|
Capi.
|
---|
| +15.15% | 1.34B | | +2.80% | 101B | | +1.20% | 65.99B | | +44.29% | 41.98B | | +15.99% | 38.65B | | +3.89% | 32.16B | | +6.82% | 19.21B | | +12.32% | 16.76B | | +17.69% | 15.07B | | +8.31% | 14.82B |
Other Commodity Chemicals
|